Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guilin Tang

Showing results (211-220 of 344) with videos related to

Pageof 35
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|May 9, 2025
Unusually Indolent CML: Absence of Complete Cytogenetic Response after 10 Years of Tyrosine Kinase Inhibitor TherapyQiudan Shen, Fadi G Haddad, Elias J Jabbour, et al.
Archives of Pathology & Laboratory Medicine|November 27, 2025
Current and Future Utilization of Optical Genome Mapping: Insights From the 2024 College of American Pathologists Supplemental QuestionnaireJuli-Anne Gardner, Rangsinee Nusapan, Julian Tan, et al.
Pathology|July 21, 2022
Expression pattern and diagnostic utility of BCL11B in mature T- and NK-cell neoplasmsHong Fang, Joseph D Khoury, Carlos A Torres-Cabala, et al.
Human Pathology|November 22, 2020
MYC expression is associated with older age, common morphology, increased MYC copy number, and poorer prognosis in patients with ALK+ anaplastic large cell lymphomaKirill A Lyapichev, Guilin Tang, Shaoying Li, et al.
Blood Advances|January 18, 2025
Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma with novel FGFR1 fusion treated with pemigatinibCarlos A Torres-Cabala, Julia Arreola Yescas, Yue Zhang, et al.
American Journal of Hematology|March 6, 2023
Outcomes of adult patients with relapsed/refractory CRLF2 rearranged B-cell acute lymphoblastic leukemiaSai Prasad Desikan, Jayastu Senapati, Elias Jabbour, et al.
NPJ Precision Oncology|September 18, 2023
Targeted single-cell proteomic analysis identifies new liquid biopsy biomarkers associated with multiple myelomaSonia M Setayesh, Libere J Ndacayisaba, Kate E Rappard, et al.
Annals of Hematology|December 30, 2017
Bone marrow findings in blast phase of polycythemia veraJuliana E Hidalgo López, Adrian Carballo-Zarate, Srdan Verstovsek, et al.
British Journal of Haematology|June 1, 2022
Myeloid neoplasms with 8q24/MYC rearrangement are frequently associated with myelodysplasia, complex karyotype, TP53 alterations, and inferior survivalXiaoqiong Wang, Guilin Tang, Zhihong Hu, et al.
Journal of Hematology & Oncology|May 9, 2015
TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseasesChi Young Ok, Keyur P Patel, Guillermo Garcia-Manero, et al.
Pageof 35

Showing results (211-220 of 344) with videos related to

Sort By:
Pageof 35
Clinical Lymphoma, Myeloma & Leukemia|May 9, 2025
Unusually Indolent CML: Absence of Complete Cytogenetic Response after 10 Years of Tyrosine Kinase Inhibitor TherapyQiudan Shen, Fadi G Haddad, Elias J Jabbour, et al.
Archives of Pathology & Laboratory Medicine|November 27, 2025
Current and Future Utilization of Optical Genome Mapping: Insights From the 2024 College of American Pathologists Supplemental QuestionnaireJuli-Anne Gardner, Rangsinee Nusapan, Julian Tan, et al.
Pathology|July 21, 2022
Expression pattern and diagnostic utility of BCL11B in mature T- and NK-cell neoplasmsHong Fang, Joseph D Khoury, Carlos A Torres-Cabala, et al.
Human Pathology|November 22, 2020
MYC expression is associated with older age, common morphology, increased MYC copy number, and poorer prognosis in patients with ALK+ anaplastic large cell lymphomaKirill A Lyapichev, Guilin Tang, Shaoying Li, et al.
Blood Advances|January 18, 2025
Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma with novel FGFR1 fusion treated with pemigatinibCarlos A Torres-Cabala, Julia Arreola Yescas, Yue Zhang, et al.
American Journal of Hematology|March 6, 2023
Outcomes of adult patients with relapsed/refractory CRLF2 rearranged B-cell acute lymphoblastic leukemiaSai Prasad Desikan, Jayastu Senapati, Elias Jabbour, et al.
NPJ Precision Oncology|September 18, 2023
Targeted single-cell proteomic analysis identifies new liquid biopsy biomarkers associated with multiple myelomaSonia M Setayesh, Libere J Ndacayisaba, Kate E Rappard, et al.
Annals of Hematology|December 30, 2017
Bone marrow findings in blast phase of polycythemia veraJuliana E Hidalgo López, Adrian Carballo-Zarate, Srdan Verstovsek, et al.
British Journal of Haematology|June 1, 2022
Myeloid neoplasms with 8q24/MYC rearrangement are frequently associated with myelodysplasia, complex karyotype, TP53 alterations, and inferior survivalXiaoqiong Wang, Guilin Tang, Zhihong Hu, et al.
Journal of Hematology & Oncology|May 9, 2015
TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseasesChi Young Ok, Keyur P Patel, Guillermo Garcia-Manero, et al.
Pageof 35